Teva Pharmaceutical Industries Gets FDA Approval for Generic Heartburn Drug   
04:10pm 14/08/2007
  Teva Pharmaceutical Industries Gets FDA Approval for Generic Heartburn Drug. "Teva agreed not to launch its products until the earlier of a denial of the preliminary injunction or Sept. 7" Teva Pharmaceutical Industries Ltd. on Thursday said federal regulators granted final approval of its application to market its generic version of Wyeth's Protonix heartburn treatment. via Canadian Business Magazine.
IBM filters out fake medicines with new system. IBM has launched an electronic system to assist the pharmaceutical industry in stopping drug counterfeiting. via The London News.Net.
Wyeth Rated Best in Pharmaceutical Industry on The Wall Street Journal Patent Scorecard. "Wyeth has made considerable effort to increase its scientific strength via ongoing investment in our people, technology and resources, with an ultimate goal of delivering to patients and doctors two new medicines each year" Wyeth announced today that the August 7, 2007 issue of The Wall Street Journal Patent Scorecard ranks Wyeth first among 35 global pharmaceutical companies evaluated for patent-based intellectual property, as.. via Med Ad News.
Spending on Product Lifecycle Management by the Pharmaceutical.. Aug 7, 2007 - Research and Markets has announced the addition of Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012 to their offering. via Med Ad News.		  
     
 
Cardinal Health 4Q earnings jump on sale of operation   
04:10pm 14/08/2007
  Cardinal Health 4Q earnings jump on sale of operation. DUBLIN, Ohio - Medical products and services company Cardinal Health Inc. said Thursday that its fourth-quarter profits rose 180 percent following the sale of its pharmaceutical technologies and services.. via News-Messenger.
Health Minister not popular with voters. "The most favourable opinions were reserved for the individual health practitioners with whom respondents have personal contact" Health Minister Tony Abbott might be an expert at criticising Labor frontbenchers in parliament, but his verbal barbs have not endeared him to voters. via The West Australian.
AHF Welcomes FDA Approval of Pfizer's Selzentry; Urges Industry to.. "We welcome the FDA approval of this clinically promising new drug into the arsenal of available AIDS treatments, particularly for use by patients who have developed resistance to many of the current antiretroviral regimens available today" However, AHF urged both Pfizer and the pharmaceutical industry as a whole to show some restraint as companies set prices for several new AIDS drugs that are expected to come to market over the next year. via Rehab Management.		  
     
 
U.S., Canada reviewing Nexium, see no heart risk   
10:10am 11/08/2007
  U.S., Canada reviewing Nexium, see no heart risk. "Health-care providers should not change their prescribing practices and patients should not change their use of these products at this time." By Lisa RichwineWASHINGTON - U.S. and Canadian regulators said on Thursday they were reviewing the safety of AstraZeneca Plc's widely used stomach drugs, Nexium and Prilosec, after data raised concern about heart problems with long-term use.But the U.S. Food and Drug Administration and Health Canada said their preliminary analyses did not show an increased heart risk and that doctors should not change prescribing practices at the moment.AstraZeneca shares fell more than 3 percent in New York and London trading. Nexium is the company's top-selling drug and was the second best selling drug in the world in 2006, according to drug information firm IMS Health. The company reported $5.2 billion in Nexium sales last year. Read more.
Fat cats facing soaring diabetes. Cat owners have been urged to watch the waistlines of their pets as a rising number of felines are diagnosed with obesity-related diabetes. via Jenkins Journal.
Man dies in custody; family says it shouldn't have happened. "Nobody knows anything. Nobody tells us anything." Milford's Edmar Alves de Araujo died hours after he was arrested in Rhode Island and handed over to immigration officials Tuesday, and his sister says his death could have been prevented if he was given needed.. via Milford Daily News.		  
     
 
KV partner gets FDA approval for menopause drug   
10:10pm 07/08/2007
  KV partner gets FDA approval for menopause drug. "We look forward to launching this product during the second half of fiscal 2008 and to its contribution to the growth of our branded business moving forward." St. Louis Business Journal - 11:09 AM CDT Monday, July 30, 2007 VIVUS Inc. said Monday it received approval from the U.S. Food & Drug Administration to begin marketing EvaMist, a drug used to alleviate.. via St. Louis Business Journal.
The Drug Advertising Blame Game. In case you are wondering who and what to blame for everything evil about the pharmaceutical industry, consider the list of "10 reforms that drug advertising needs right now." This list was compiled by Jim.. via Pharma Marketing Blog.
McKesson Net Income Increases 28 Percent on Records Systems, Drug Sales. McKesson Corp., the biggest U.S. drug distributor, said profit rose 28 percent as the company sold more health-records systems and cheap generic drugs. via Bloomberg.
CVS Caremark Reports Q2 and July Results. CVS Caremark said net earnings for the second quarter ended June 30, 2007, increased 114.1% to $723.6 compared with net earnings of $337.9 millionin the comparable 2006 period. via Retail Merchandiser.
Merger boosts CVS Caremark results. "The traditional CVS business is on fire" CVS Caremark Corp. reported second-quarter profit and sales that rose more than analysts estimated on contributions from pharmacy-benefits manager Caremark RX Inc., which CVS bought for $27 billion in March. via Denton Record-Chronicle.
Caliper Life Sciences Develops Customized Transfection System for Boehringer Ingelheim. "The capability to develop highly reliable integrated systems illustrates our commitment to laboratory automation and robotics, and to providing the pharmaceutical industry with innovative research tools that meet unique needs" Caliper Life Sciences, Inc., an established leader in the field of robotics, is working with the pharmaceutical industry to develop customized robotic transfection systems for protein expression. via Med Ad News.		  
     
 
Nicotine may slow progression of rheumatoid arthritis   
10:11am 04/08/2007
  Nicotine may slow progression of rheumatoid arthritis. "The cardiovascular hazards of smoking certainly outweigh the potential anti-inflammatory benefits of nicotine" By Joene HendryNEW YORK - In people with rheumatoid arthritis, heavy cigarette smoking appears to slow the rate of joint destruction, new research suggests."Potentially, this may be due to the anti-inflammatory properties of nicotine," Dr. Axel Finckh, University Hospital of Geneva, Switzerland told Health.Cigarette smoking is a known risk factor for rheumatoid arthritis, a chronic inflammatory disease that causes progressive joint destruction, disability, and premature death, Finckh and colleagues reported in the Annals of the Rheumatic Diseases. Read more.
Success or Failure of Antidepressant Citalopram Predicted by Gene Variation. "New techniques have led to advances that would have been inconceivable a few years ago and are making individualized treatment an achievable goal." BETHESDA, Md., Aug.1, 2007--A variation in a gene called GRIK4 appears to make people with depression more likely to respond to the medication citalopram than are people without the variation, a study by the.. via Med Ad News.
Nicotine hooks youths quickly. "We know very little about the natural history of dependence" A young cigarette smoker can begin to feel powerful desires for nicotine within two days of first inhaling, a new study has found, and about half of children who become addicted report symptoms of dependence by.. via Montereyherald.com.
FDA panel suggests relaxing acne drug pregnancy program. "Why does that not represent a major failure of the iPledge system?" Health advisers are urging slightly more flexibility in rules designed to prevent pregnancies among women taking an acne drug that has caused birth defects - even though women taking the drug still are getting.. via Arizona Daily Star.		  
     
 
Generic Drugs May Give Kickbacks To Docs   
10:11am 04/08/2007
  Generic Drugs May Give Kickbacks To Docs. "I'm shocked. They're paying the doctors? Yes. I'm shocked." Health insurers are giving doctors incentives, sometimes in cash, to switch patients to generic brands, Boston television station WCVB has reported. via KCTV5.
China's pharmarceutical watchdog suspends more leukemia drugs in risk probe. China's drug watchdog has suspended sales of two more batches of methotrexate made by Shanghai Hualian Pharmaceutical as it continues its month-long investigation of the drug. via People's Daily Online.
Golfer fails drugs test. Italian golfer Alessandro Pissilli has been suspended after failing a drug test, the Italian Olympic Committee said Wednesday. via Slam Sports.
Amgen Challenges New Medicare Policy. "In our view, restricting coverage in this way is unreasonable, impractical and unworkable" Amgen has challenged a portion of a new coverage policy issued by the agency that runs Medicare, saying it will limit cancer patients' access to drugs that fight anemia. via New York Times.		  
     
 
Medicare Announces New Proposed Clinical Research Policy, USA   
04:10pm 31/07/2007
  Medicare Announces New Proposed Clinical Research Policy, USA. The Centers for Medicare & Medicaid Services announced the reopening of its clinical trial policy national coverage determination and is releasing a proposed decision memorandum for public comment. The public comment period will last for 30 days and a final decision will be released 60 days after that.
BioCryst Initiates Phase II Clinical Trial To Evaluate Intravenous Peramivir In Patients Hospitalized With Influenza. BioCryst Pharmaceuticals, Inc. today announced the initiation of a Phase II clinical trial in hospitalized patients using an intravenous formulation of peramivir, the company's lead influenza neuraminidase inhibitor. The trial will compare the efficacy and safety of intravenous peramivir to orally administered oseltamivir in patients who require hospitalization due to acute influenza.		  
     
 
Phone Counseling Can Coax Reluctant Alcoholism Patients Into Treatment   
04:10pm 31/07/2007
  Phone Counseling Can Coax Reluctant Alcoholism Patients Into Treatment. Telephone counseling might be an effective primary care intervention for men who are not seeking treatment for their alcohol dependence or abuse, according to a new study.Men benefited more from the short-term telephone counseling used in the study, which appears in the August issue of the journal Alcoholism: Clinical and Experimental Research.Lead researcher Richard Brown, M.D.
CoAxia Announces First Use Of NeuroFlo Technology In Study For Stroke Patients After Attempted Thrombolysis. CoAxia, Inc. of Maple Grove, MN, today announced that investigation of its NeuroFlo perfusion augmentation technology has been extended to patients who do not respond to thrombolysis with the drug tissue plasminogen activator, the only stroke therapy currently approved by the US FDA.
InterMune Submits CTA Amendment For ITMN-191 And Provides Update On Clinical Development Program. InterMune, Inc. and its partner Roche today announced that on Monday, July 23rd, they submitted an amended Clinical Trial Authorization with the relevant European regulatory authority, the final step before initiating a Phase 1b study of Hepatitis C Virus protease inhibitor ITMN-191 in chronic hepatitis C patients.
Use Of Hip Protector Does Not Reduce Risk Of Hip Fracture For Nursing Home Residents. Use of an energy-absorbing hip protector did not provide a protective effect against hip fracture for nursing home residents, adding to increasing evidence that hip protectors, as currently designed, are not effective for preventing hip fractures, according to a study in the July 25 issue of JAMA.
BioMS Medical's Relapsing-remitting Multiple Sclerosis Trial Receives Positive Review From Data Safety Monitoring Board. BioMS Medical Corp., a leading developer in the treatment of multiple sclerosis, today announced that the independent Data Safety Monitoring Board for the Company's phase II MINDSET-01 trial of MBP8298 in patients with relapsing-remitting MS has completed a safety analysis and recommended that the trial continue as per the protocol.
Vicriviroc Demonstrates Potent Viral Suppression Through 48 Weeks Of Therapy In ACTG Phase II Study In Treatment-Experienced HIV Patients. Schering-Plough Corporation today reported that results from a Phase II clinical trial showed vicriviroc, its investigational CCR5 antagonist, demonstrated potent and sustained viral suppression through 48 weeks of therapy in treatment-experienced HIV patients, when administered in once-daily doses in combination with an optimized ritonavir-boosted protease inhibitor - containing antiretroviral regimen.		  
     
 
Newer Breast Cancer Drugs Appear to Boost Life Spans   
04:11pm 27/07/2007
  Newer Breast Cancer Drugs Appear to Boost Life Spans. "We're making a leap of faith as to what we're doing, how we're spending our resources, that we're actually allowing them to live longer" A newer generation of breast cancer medications added months to the lives of patients with the most advanced form of the disease, according to the first study of its kind. via LiveScience.
Biovail shares plummet on FDA decision but investors shouldn't worry: analyst. "Drug patents expire, the competition comes in. So just by the sheer fact that it's being delayed by one year, it will have a long-term impact." Biovail Corp. lost about one-fifth of its value Friday after the Toronto-area drug manufacturer said it has failed to win approval from the U.S. Food and Drug Administration for a component of a new.. via Canadian Business Magazine.
Drug Safety Critic Hurls His Darts From the Inside. "This is a genie I don't want to see let out of the bottle." Back in the '60s, when University of Michigan students were holding protests over civil rights and the Vietnam War, an undergraduate named Steven E. Nissen was at the center of the political dissent. via New York Times.		  
     
 
Advocacy in Whose Interest? - The Pharmaceutical Industry, the   
04:10am 23/07/2007
  Advocacy in Whose Interest? - The Pharmaceutical Industry, the.. "These are people's lives that we're talking about -- nothing about stock options and stock value and how this would affect companies'] bottom line. That would be insulting to us to have discussions like that " Advocacy in Whose Interest? - The Pharmaceutical Industry, the Epilepsy Foundation, and Generic Anti-Epileptic Prescribing Just in time for another lazy summer weekend comes this article from the Wall Street.. via Health Care Renewal.
Par Pharmaceutical Announces Agreement with Ortho-McNeil to Settle Ultracet Patent Litigation. Par Pharmaceutical Companies, Inc. today announced it has entered into a settlement and license agreement with Ortho-McNeil Pharmaceutical, Inc. via Med Ad News.
Barr confirms Xopenex patent challenge. Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sepracor Inc. via Medical News.
Dickson County Property Transfers. Scott R. Springer and Donna J. Springer to Will Paul Drake and Barbara J. Drake, lot in Peery and Hogin, $38,000. David Adcox to D and K Inc. via The Tennessean.
FDA Approves Extina for the Treatment of Seborrheic Dermatitis. "We are very pleased with the robust data obtained in the pivotal Phase III clinical trial evaluating the safety and efficacy of Extina" Stiefel Laboratories, Inc. today announced that the U.S. Food and Drug Administration has approved its new drug application for Extina Foam, 2% for the treatment of seborrheic dermatitis. via Med Ad News.
WVU Maintenance Worker Killed. Posted Friday, July 20, 2007 ; 08:57 AM Updated Friday, July 20, 2007 ; 09:17 AM West Virginia University police: worker fell at stadium. via WVNS-TV Ghent.		  
     
 
McKesson to buy patient-tracking software company   
04:10am 23/07/2007
  McKesson to buy patient-tracking software company. San Francisco Business Times - 3:00 PM PDT Monday, July 16, 2007 McKesson Corp. has agreed to acquire Awarix Inc. via Bizjournals.
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Provigil. Caraco Pharmaceutical Laboratories, Ltd., announced today that the US Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application for Modafinil Tablets, 100mg.. via Med Ad News.
Trial to start for man who allegedly gave son lethal dose of oxycodone. "He kept saying, 'I want to die, Dad. I want to die,'" A man who told authorities his 10-year-old son demanded a deadly mix of soda and pain killers is scheduled to go on trial this week. via Journal-Gazette.
McKesson agrees to buy Awarix. "Our customers have requested systems that can help maximize throughput and associated revenue while recommending the most efficient strategy to move a patient through the care process" McKesson Corp. on Monday said it has agreed to buy privately held Awarix Inc., maker of a color-coded, electronic patient care management system for hospitals. via MarketWatch.
Forest Labs Investors May Be Out Of The Woods. UBS gives investors a prescription to buy Forest Laboratories. Shares of the drug maker rose 1.7%, or 79 cents, to $46.71 Wednesday as UBS lifted its rating to "buy" from "neutral" after concluding Forest.. via Forbes.
Arpida Reports Positive Results of Second Pivotal Phase III Trial With Intravenous Iclaprim in cSSSI. REINACH and BASEL, Switzerland, July 16 -- - Safety Profile Confirmed Arpida Ltd. via Earth Times.		  
     
 
Albany Medical Center Seeks Volunteers For Alzheimer's Study, USA   
10:10am 17/07/2007
  Albany Medical Center Seeks Volunteers For Alzheimer's Study, USA. Doctors at Albany Medical Center are seeking volunteers for a study to determine whether there is a link between the level of copper in the body and the advancement of Alzheimer's disease. The research study will compare three groups: patients with Alzheimer's, patients with Parkinson's disease, and healthy individuals to analyze the levels of copper, other trace metals and proteins found in each population.
CV Therapeutics Identifies Potential Anti-Diabetic Mechanism Of Action For Ranexa. CV Therapeutics, Inc. announced today that researchers have completed preliminary preclinical studies showing that ranolazine increased glucose stimulated insulin secretion in pancreatic beta cells. In separate experiments using preclinical models of insulin resistance, ranolazine also improved glucose homeostasis.
In HIV-Infected Treatment-Experienced Patients Darunavir-Ritonavir Better Than Lopinavir-Ritonavir. Darunavir-ritonavir should be considered as a treatment option across the range of treatment-experienced patients with HIV infection, conclude Jose Madruga and colleagues in an Article in this week's issue of The Lancet.
FDA Approves Phase I Clinical Trial Of Topaz Pharmaceuticals' New Head Lice Treatment. Topaz Pharmaceuticals LLC, a pharmaceutical company dedicated to the health and well being of children, announced today that the U.S. Food and Drug Administration has approved an investigational new drug application; allowing Topaz to begin clinical trials of the company's topical solution for the treatment of head lice.		  
     
 
Angiotech Completes Enrolment In Its Central Venous Catheter Pivotal Study   
10:10am 17/07/2007
  Angiotech Completes Enrolment In Its Central Venous Catheter Pivotal Study. Angiotech Pharmaceuticals, Inc., a global specialty pharmaceutical and medical device company, today announced the completion of enrolment in its Central Venous Catheter Pivotal Study, which is designed to examine the safety and efficacy of Angiotech's 5-Fluorouracil coated CVC in preventing bacterial catheter colonization when compared to another leading anti-infective CVC.
Children Should Be Included In Research To Make Breakthroughs In Child Medicine, Says Expert. Scientists will only make real breakthroughs in children's medicine if they include children in research programmes as well as adults, according to a leading paediatric expert.Professor John Warner was speaking at the opening of the Paediatric Research Unit, the UK's first unit solely devoted to paediatric clinical research. The unit is run by researchers from Imperial College London and St Mary's Hospital, and it is based next to the hospital's paediatric wards in Paddington.
Peregrine Pharmaceuticals Submits Clinical Protocol To Initiate Bavituximab Phase II Trial In Lung Cancer Patients. Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus infection, today announced that it has submitted a clinical protocol with the Drug Controller General of India for a Phase II trial of bavituximab in combination with chemotherapy in patients with non-small cell lung cancer.
Dynavax Completes Enrollment Of HEPLISAV Phase 3. Dynavax Technologies Corporation announced today the completion of enrollment of its Phase 3 pivotal clinical trial of HEPLISAV, its novel hepatitis B virus vaccine. Dynavax's U.S. safety and immunogenicity study - a second key clinical trial designed to support the licensure of HEPLISAV - is expected to complete enrollment before the end of this month.
Novo Nordisk Increases Transparency On Clinical Trials And Bioethics. Novo Nordisk is taking the lead in communicating with the public through the launch of two new websites dedicated to clinical trials and bioethics respectively. Both sites are aimed at a wide target group including patients, doctors, investors, experts and the general public. "The new clinical trials portal will provide an overview of all Novo Nordisk's clinical trials around the world. It will cover phase 2, 3 and 4 trials, which means both before and after the market entry point.		  
     
 
Manhattan Pharmaceuticals Announces Results Of Phase 2a Studies For Oral Oleoyl-estrone   
10:10am 17/07/2007
  Manhattan Pharmaceuticals Announces Results Of Phase 2a Studies For Oral Oleoyl-estrone. Manhattan Pharmaceuticals, Inc. today announced results of the company's two Phase 2a clinical trials of oral Oleoyl-estrone. The results of both randomized, double-blind, placebo-controlled studies, one in common obesity and the other in morbid obesity, demonstrated no statistically or clinically meaningful placebo adjusted weight loss for any of the treatment arms evaluated.
Medicare Announces New Clinical Trial Policy. The Centers for Medicare & Medicaid Services announced last monday its revised clinical trial policy national coverage determination which addresses Medicare coverage when beneficiaries participate in clinical research trials. CMS published its proposed Clinical Trial Policy Decision Memorandum on April 10, 2007.
Catalyst Pharmaceutical Partners, Inc. Initiates U.S. Phase II Clinical Trial Of CPP-109 In Patients With Cocaine Dependence. Catalyst Pharmaceutical Partners, Inc. a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today announced that it has initiated its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial of CPP-109 in patients with cocaine dependence.
TRACON Pharmaceuticals And Micromet Announce The Initiation Of Phase 1 Clinical Trial With TRC093, A Humanized Antibody For Cancer Treatment. TRACON Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of products for oncology and ophthalmology treatment, and Micromet, Inc.,, a biopharmaceutical company focused on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, announced today that TRACON has started the treatment of the first cancer patient in a Phase 1 clinical trial with TRC093.		  
     
 
Highlights. "Don't Forget   
04:11am 12/07/2007
  Highlights. "Don't Forget the Lyrics!" is the second karaoke-based reality show to premiere in as many days, joining NBC's "The Singing Bee." Wayne Brady hosts this one, in which contestants sing alongside a studio band to lyrics projected on a screen.. until the music stops, the words..
Springfield, Vt., Wins the 'Simpsons Movie' Premiere. SPRINGFIELD, Vt., July 10 -- Maybe it was the pink doughnut. Maybe it was the clever homemade video, or small-town charm.
Two Wands Up! It's jump-out-of-your-seat scary; it's surprisingly funny; it's visually dazzling.
KEEGAN THEATRE'S NEW SEASON. For its 10th season, the Keegan Theatre, which specializes in Irish plays, will present four shows at Church Street Theater and four as part of its more experimental, bare-bones New Island Project at tiny Theatre on the Run in Arlington.
Return to Sender. THE ITALIAN LETTER How the Bush Administration Used a Fake Letter to Build the Case for War in Iraq.		  
     
 
Meet Emma Watson. Birthday: April 15, 1990   
04:11am 12/07/2007
  Meet Emma Watson. Birthday: April 15, 1990. Home: Oxfordshire, England. Brother: Alex, 14. "He's a little comedian. Very, very funny. He keeps me down to earth." Pets: Cats named Bubbles and Domino. Music: "Everything's good, literally everything. I like hip-hop to dance to, I think the last CD I bought was Russi..
The Birds and the Bees and the Gelada Baboons. BEVERLY HILLS, Calif., July 10 Day 1 of Summer TV Press Tour 2007 and already I am an expert on duck rape. You, too, can be an expert if you watch PBS's "What Females Want and Males Will Do" -- one of the highlights of the "Nature" franchise's upcoming 26th season on the public television network.
AMERICAN CENTURY THEATER'S 2007-08 LINEUP. The American Century Theater, which focuses on rarely staged American plays, will present five shows at Gunston Arts Center in Arlington.		  
     
 
A Magical Transformation   
04:11am 12/07/2007
  A Magical Transformation. Dressed in a short black dress and long black boots, Emma Watson looked more like a fashion model than a schoolgirl as she chatted at a posh hotel in London, England.
Rapper Mickey Avalon, Reaching a New Low. Sporting skintight Levi's, a tangled coif and copious guy-liner, and teeming with tattoos, Mickey Avalon looks like a wannabe rock star freshly plucked from the gutters of the Sunset Strip. But hand the dude a mike and he's ready to spit rhymes. MySpace generation, meet your Kid Rock.
Remister in Your Duties. Dear Miss Manners: I work for a multinational company. I frequently contact strangers who work for branches of our company in other countries via e-mail, seeking information for various projects. Since we haven't been formally introduced, should I use Mr./Ms., or should I use their first names, as..
'Live Earth' Doesn't Play Well With Viewers. "Live Earth" was dead weight for NBC this weekend.		  
     
 
TELL ME ABOUT IT ®. Carolyn Hax is away   
04:11am 06/07/2007
  TELL ME ABOUT IT ®. Carolyn Hax is away. The following is adapted from summer 2006 live discussions on washingtonpost.com.
Oral Argument. Dear Miss Manners: In my dental practice, I see a lot of children who are grammatically challenged. As their dentist, would it be proper for me to gently correct them of their trespasses against the English language, or should I turn a deaf ear to their oral cavity?.
Not That Anyone Was Watching.. As the annual pre-Fourth-of-July pall began to settle over the TV landscape, CBS won last week's ratings battle even though it attracted an average of just 6.8 million viewers -- the third-smallest winning audience ever, according to Nielsen Media Research.
Bridge. South seems to have four unavoidable losers at today's four hearts, but a capable declarer can read the cards and make one of those losers go up in smoke. Marty Hirschman solved the problem in the Mixed Pairs at the ACBL Spring Championships.
TODAY'S NEWS. · Good news and bad for video gamers: A new study found that kids who played video games on school days, not surprisingly, spent less time reading and doing homework. But gaming didn't interfere with kids spending time with family and friends or playing sports.
OTHER NEWS. · Scientists in Vietnam have found the world's largest-known group of grey-shanked doucs. The discovery of 116 of the tree-dwelling monkeys is good news for the survival chances of one of the world's 25 most-endangered primates.		  
     
 
FOLGER THEATRE'S NEW SEASON   
04:11am 06/07/2007
  FOLGER THEATRE'S NEW SEASON. The Folger Theatre, which performs in the Elizabethan Theatre at the Folger Shakespeare Library on Capitol Hill, will offer a three-play subscription series plus a medieval mystery play as a special Christmas event.
Hall & Oates' Blue-Eyed Soul Needs No Bifocals. Pop duos, commonplace on the singles charts in the '70s, have become as passe as comedy pairings. But Hall & Oates, who appeared at the Music Center at Strathmore on Monday backed by a large band, remain fine ambassadors of the era of the ampersand.		  
     
 
BioForm Medical Enrolls   
10:14am 02/07/2007
  BioForm Medical Enrolls First Patient In Clinical Trial Of CryoLife's BioGlue Surgical Adhesive For Use In Cosmetic And Plastic Surgery. CryoLife, Inc. and BioForm Medical, Inc. announced that the first patient has been enrolled in a clinical study evaluating BioGlue Surgical Adhesive as a method of fixation in brow lifts.
AHN Sports News. AHN is a leading provider of entertainment news and our Celebrity News Service provides the latest celebrity news, gossip, stories, interviews and features to online, print, broadcast and non-traditional news outlets worldwide.
AHN Celebrity News, Gossip and Buzz. AHN is a leading provider of entertainment news and our Celebrity News Service provides the latest celebrity news, gossip, stories, interviews and features to online, print, broadcast and non-traditional news outlets worldwide.
Phase II Results Show Once-Daily Dosing Of Human GLP-1 Analog Liraglutide, Brings Patients To A1c Target. According to findings presented today at the 67th Scientific Sessions of the American Diabetes Association in Chicago, Illinois, the investigational treatment liraglutide, a once- daily dose of human GLP-1 analog under development by Novo Nordisk for the treatment of type 2 diabetes significantly improved glycemic control by reducing both fasting and post-meal glucose levels in people with type 2 diabetes.
Dynavax Starts HEPLISAV Phase 3 In Europe; U.S. Study; And Phase 2 In ESRD In Canada. Dynavax Technologies Corporation announced today the initiation of three clinical trials to support licensure of HEPLISAV, its novel hepatitis B virus vaccine: -- The ongoing multi-center pivotal Phase 3 trial in Canada has been expanded to include seven sites in Germany as planned; -- A U.S. study is enrolling subjects 11 through 55 years of age. The data from the U.S.		  
     
 
  rebeccahko8
 
 
skip  
 
 

Advertisement